These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. High-dose chemotherapy with autologous marrow transplantation for malignant melanoma. Case reports and literature review. Kessinger A J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):337-43. PubMed ID: 3882786 [TBL] [Abstract][Full Text] [Related]
17. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Elkordy M; Crump M; Vredenburgh JJ; Petros WP; Hussein A; Rubin P; Ross M; Gilbert C; Modlin C; Meisenberg B; Coniglio D; Rabinowitz J; Laughlin M; Kurtzberg J; Peters WP Bone Marrow Transplant; 1997 Feb; 19(4):315-22. PubMed ID: 9051240 [TBL] [Abstract][Full Text] [Related]
18. High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease. Zulian GB; Selby P; Milan S; Nandi A; Gore M; Forgeson G; Perren TJ; McElwain TJ Br J Cancer; 1989 Apr; 59(4):631-5. PubMed ID: 2653400 [TBL] [Abstract][Full Text] [Related]
19. High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation Group. Wolff SN; Herzig RH; Fay JW; LeMaistre CF; Frei-Lahr D; Lowder J; Bolwell B; Giannone L; Herzig GP J Clin Oncol; 1989 Feb; 7(2):245-9. PubMed ID: 2492594 [TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation. Cornbleet MA; McElwain TJ; Kumar PJ; Filshie J; Selby P; Carter RL; Hedley DW; Clark ML; Millar JL Br J Cancer; 1983 Sep; 48(3):329-34. PubMed ID: 6351883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]